Pricing Log in Create free account

Profound Medical (PROF) vs RxSight, Inc. (RXST)

Profound Medical and RxSight, Inc. are both Medical Devices companies. Profound Medical is the larger, with a market value of $251.3M against $190.4M — 1.3× the size. Profound Medical grew revenue faster over the last twelve months: 65.3% against −14.3%. RxSight, Inc. has the higher net margin (−43.8% vs −137.5%) and the lower return on invested capital (−16,845.7% vs −156.6%). Across the 18 metrics below, RxSight, Inc. leads on 12 and Profound Medical on 6.

Valuation

Metric PROF RXST Medical Devices median
P/E n/m n/m 25.58
P/S 10.63 1.52 2.54
P/B 5.91 0.72 2.48
Price to free cash flow n/m 9.91 28.81
EV/EBITDA n/m 0.77 11.51
EV/Sales 9.60 (0.41) 2.72
Earnings yield (13.55%) (28.87%) (12.82%)
Free cash flow yield (12.80%) 10.09% (8.18%)

Profitability

Metric PROF RXST Medical Devices median
Gross margin 73.86% 76.13% 57.76%
Operating margin (145.08%) (50.44%) (15.07%)
Net margin (137.51%) (43.80%) (14.45%)
Free cash flow margin (133.29%) 15.30% (3.88%)
Return on equity (87.04%) (20.10%) (10.35%)
Return on assets (64.68%) (16.44%) (17.26%)
Return on invested capital (156.58%) (16,845.67%) (5.27%)

Growth

Metric PROF RXST Medical Devices median
Revenue growth (TTM) 65.26% (14.26%) 10.41%
EPS growth (last fiscal year) (25.89%) (33.80%) 28.17%
Revenue growth, 5-year CAGR 17.12% 55.74% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PROF RXST Medical Devices median
Debt to equity 0.11 0.00 0.04
Current ratio 4.54 4.20 2.74
Net debt to EBITDA 1.36 4.27 0.54

Dividend

Metric PROF RXST Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric PROF RXST Medical Devices median
Market cap 251.33m 190.36m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack